Arcus Biosciences (RCUS)
(Real Time Quote from BATS)
$17.70 USD
+0.15 (0.86%)
Updated May 16, 2024 12:38 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Brokerage Reports
Arcus Biosciences, Inc. [RCUS]
Reports for Purchase
Showing records 41 - 60 ( 119 total )
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Q4 Financials; ARC-7 Data Ahead; Broad TIGIT Plan Continues Expansion
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE- The Week Ahead in Life Sciences
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
AB521 Demonstrates Promising Profile; Clinical Program on Track
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Q3 Financials; Partner Gilead Set for Dom Decision; Quemli Update Ahead
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Abstracts and Sessions Relevant to Covered Companies at AACR-NCI-EORTC
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Arcus Biosciences, Inc.
Industry: Medical - Biomedical and Genetics
Focus on Cancer Intrinsic Pipeline Targets for Triple Meeting
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R